CDMO: Lipids for LNPs

About EuroAPI

EuroAPI's mission is to ensure a reliable, high-quality supply of essential active pharmaceutical ingredients (APIs) to secure global healthcare sovereignty. Since its 2022 spin-off and public listing, it has established itself as a critical, independent supplier with a vast portfolio and a resilient European manufacturing footprint. Its strategy is built on four pillars: quality and compliance, customer centricity, operational excellence, and sustainability, positioning it as a key enabler for both established generics and novel drug development.

Therapeutic Areas